Health Care & Life Sciences » Biotechnology | Beijing Tiantan Biological Products Corp. Ltd.

Beijing Tiantan Biological Products Corp. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,820
1,814
1,609
2,109
1,739
2,898
Cost of Goods Sold (COGS) incl. D&A
811
794
867
1,043
801
1,580
Gross Income
1,009
1,020
742
1,066
938
1,318
SG&A Expense
403
561
316
599
346
467
EBIT
581
399
350
-
586
851
Unusual Expense
-
15
33
2
8
-
Non Operating Income/Expense
14
1
16
23
790
9
Interest Expense
29
129
125
104
41
7
Pretax Income
547
304
198
370
1,363
868
Income Tax
85
77
82
74
117
132
Consolidated Net Income
461
226
116
296
1,246
736
Net Income
372
128
10
257
1,180
509
Net Income After Extraordinaries
372
128
10
257
1,180
509
Net Income Available to Common
372
128
10
257
1,180
509
EPS (Basic)
0.43
0.15
0.01
0.29
1.35
0.49
Basic Shares Outstanding
871
871
871
871
871
1,045
EPS (Diluted)
0.43
0.15
0.01
0.29
1.35
0.49
Diluted Shares Outstanding
871
871
871
871
871
1,045
EBITDA
673
510
547
662
688
984
Other Operating Expense
26
61
76
21
6
-
Non-Operating Interest Income
4
14
14
6
21
14
Minority Interest Expense
89
98
106
39
66
226

About Beijing Tiantan Biological Products Corp.

View Profile
Address
No.4 Sanjianfang South Li
Beijing Beijing 100024
China
Employees -
Website http://www.tiantanbio.com
Updated 07/08/2019
Beijing Tiantan Biological Products Corp. Ltd. engages in the research and development, production, and sale of biological products. It offers blood albumin; intravenous, hepatitis B and tetanus immunoglobulin; coagulation factors; and protease inhibitors. The company was founded on June 8, 1998 and is headquartered in Beijing, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.